I understand that IMP can not vouch for the safety or
efficacy of any treatment offered by a PROVIDER in the THERAPIST DATABASE.
Not exact matches
The authors say: «The excellent
efficacy of DP for the
treatment of malaria in multiple countries and for chemoprevention in our high transmission area suggest that this regimen will
offer benefit in many regions in need
of improved control measures.»
Although further research into A-CRA's
efficacy in treating various combinations
of substance use and psychiatric disorders is warranted, the authors argue that there's no reason for providers to wait when it comes to
offering comprehensive
treatment to adolescents who could benefit from their help right now.
Theoretically, this precise molecular characterization
of human disease will allow us to understand the basis for disease susceptibility and environmental influence; to
offer an explanation for the different phenotypic manifestations
of the same disease; to define disease prognosis with greater accuracy; and to refine and, ideally, individualize disease
treatment for optimal therapeutic
efficacy.
Notwithstanding the survival advantage
offered by sorafenib, a great margin
of improvement may be envisaged particularly for nonresponders, as well as for those patients who experience escape from
treatment efficacy.
«Requiring new
treatments to show either greater
efficacy or acceptability than an existing standard therapy would serve as a disincentive to the development
of me - too agents that
offer little to patients other than increased costs,» they write.
In brief, the present study
offers tentative support for the long - term
efficacy of FCBT relative to CCBT 1 year following
treatment completion.